课题基金 / 基金详情

Nanoscale engineering of novel erodible drug delivery matrices

Nanoscale engineering of novel erodible drug delivery matrices
新型可溶蚀药物输送基质的纳米工程
批准号:
7084420
负责人:
ERIC M FURST
金额:
$28.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-19 至 2009-07-31

项目摘要

项目成果

ERIC M FURST的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):现代生物材料研究的范例是设计能够对特定刺激做出反应并引起期望的生物反应的材料。结构生物学向定量理解生物大分子和细胞行为的方向发展,为合理设计具有良好生物活性的材料提供了重要信息。这项建议的主要目标之一是通过生物重要蛋白质(如生长因子)和多糖之间的相互作用组装新型的非共价交联水凝胶骨架;这种结合的热力学和动力学将被操纵以控制材料的性质和释放曲线。用于控制组装的相互作用也将允许通过与细胞表面受体的配体交换来传递蛋白质。利用配体交换机制作为传递和侵蚀的策略将与许多体内过程相关,在这些过程中,细胞过度表达某些受体,通过这种独特的活性协调,基质将被应用于靶向传递生长因子用于化疗、组织工程和伤口愈合应用。 除了生产用于大分子传输的新材料外,这项工作还将利用新的定量方法来表征这些生物材料在与细胞相关的长度和时间尺度上的机械响应。示踪粒子微观流变学和激光镊子微操作等新的定量方法将被用来直接测量这些水凝胶的微观力学和松弛时间尺度。与上述合成策略相结合,这些研究将使我们能够了解非共价分子相互作用对水凝胶基质结构和流变性的具体影响。这将允许对微观机械反应、分子传递动力学以及细胞过程的长度和时间尺度的功能进行合理设计。因此,拟议的策略将导致细胞和聚合物反应耦合的材料,并将广泛影响针对特定细胞事件的新生物材料的开发。
英文摘要
DESCRIPTION (provided by applicant): The paradigm of modern biomaterials research is the design of materials that can respond to specific stimuli and elicit a desired biological response. The revolution in structural biology toward quantitative understanding of biomacromolecular and cellular behavior offers important information for the rational design of materials with desirable bioactivity. One of the primary goals of this proposal is the assembly of novel, noncovalently crosslinked hydrogel matrices via the interaction between biologically important proteins (such as growth factors) and polysaccharides; the thermodynamics and kinetics of the association will be manipulated to control materials properties and release profiles. The interactions used to control assembly will also permit delivery of the proteins by ligand exchange with cell surface receptors. Exploiting ligand exchange mechanisms as a strategy for delivery and erosion will be relevant to many in vivo processes in which cells overexpress certain receptors, and by this unique coordination of activities, the matrices will find application in the targeted delivery of growth factors for chemotherapeutic, tissue engineering, and wound healing applications. In addition to producing novel materials for macromolecular delivery, this work will also utilize new quantitative approaches for characterizing the mechanical response of these biomaterials on length and timescales that are relevant to cells. New quantitative approaches such as tracer particle microrheology and micromanipulation with laser tweezers will be applied to directly measure microscopic mechanics and relaxation timescales of these hydrogels. When coupled with the synthetic strategies above, these investigations will allow us to understand the specific impact of noncovalent molecular interactions on the structure and rheological properties of hydrogel matrices. This will permit the rational design of microscopic mechanical responses, molecular delivery kinetics, and functionality on length and timescales of cellular processes. The proposed strategies will therefore result in materials in which cellular and polymer responses are coupled, and will broadly impact the development of new biomaterials targeted to specific cellular events.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/mabi.200800284
发表时间: 2009-02-11
期刊: MACROMOLECULAR BIOSCIENCE
影响因子: 4.6
作者: [Jia, Xinqiao, Kiick, Kristi L.]
通讯作者: Kiick, Kristi L.
DOI: 10.1021/ma900766u
发表时间: 2009-07-28
期刊: Macromolecules
影响因子: 5.5
作者: [Schultz KM, Baldwin AD, Kiick KL, Furst EM]
通讯作者: Furst EM
DOI: 10.1039/b818178k
发表时间: 2009-01-01
期刊: Soft matter
影响因子: 3.4
作者: [Schultz KM, Baldwin AD, Kiick KL, Furst EM]
通讯作者: Furst EM
DOI: 10.1016/j.actbio.2008.12.004
发表时间: 2009-03
期刊: ACTA BIOMATERIALIA
影响因子: 9.7
作者: [Nie, Ting, Akins, Robert E., Jr., Kiick, Kristi L.]
通讯作者: Kiick, Kristi L.
共 7 条
    Nanoscale engineering of erodible drug delivery matrices
    • 批准号:
      6737930
    • 项目类别:
    • 资助金额:
      $27.35万
    • 财政年份:
      2003
    • 负责人:
      ERIC M FURST
    • 依托单位:
    Nanoscale engineering of novel erodible drug delivery matrices
    • 批准号:
      6801965
    • 项目类别:
    • 资助金额:
      $31.38万
    • 财政年份:
      2003
    • 负责人:
      ERIC M FURST
    • 依托单位:
    Nanoscale engineering of novel erodible drug delivery matrices
    • 批准号:
      6932457
    • 项目类别:
    • 资助金额:
      $30.61万
    • 财政年份:
      2003
    • 负责人:
      ERIC M FURST
    • 依托单位: